Leidos Holdings, Inc. (LDOS) Income Statement

The sequential acceleration from Q1 to Q2 suggests improving demand across key segments, particularly in defense and health. The 7.2% growth rate is above the trailing average, indicating that the company is gaining traction. However, the sustainability of this pace depends on continued federal budget allocations and the conversion of the $5 billion in recent awards.

The 190 basis point year-over-year expansion in gross margin suggests that Leidos is benefiting from a higher proportion of fixed-price contracts and better cost controls. This is a positive signal for profitability, though investors should monitor whether this mix shift increases execution risk. The margin improvement also supports the company's ability to invest in growth initiatives.

The modest operating leverage is evident as SG&A expenses grew slower than revenue, indicating disciplined overhead management. However, the operating margin dipped slightly from the prior quarter, suggesting that some cost pressures may be emerging. The company's ability to maintain operating margins above 11% is a testament to its scale and efficiency, but further expansion may be limited without higher revenue growth.

The reduction in COGS ratio indicates improved contract execution and possibly a shift toward higher-margin work. SG&A expenses have been well-controlled, with only a slight increase in absolute terms. This cost discipline is crucial for sustaining profitability in a competitive government contracting environment, though labor inflation remains a risk.

This quarter represents a clear inflection from the slower growth seen in late 2025, driven by strong demand and successful contract awards. The raised guidance suggests that the company expects this momentum to continue, supported by a robust pipeline. The lasting impact could be a re-rating of the stock if the company can consistently deliver on these improved metrics.